{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-055368","form_type":"8-K","ticker":null,"cik":"0001865127","company_name":"Lucy Scientific Discovery, Inc.","filed_at":"2023-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.900316+00:00","generated_at":"2026-06-13T11:16:57.049408+00:00","sec_items":["1.01","2.01","3.02","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lucy Scientific completes acquisition of Wesana's SANA-013 assets; forms Lucy Discoveries Holdings","bullets":["Acquired SANA-013, a psilocybin/CBD combination therapy for MDD, migraine, cluster headaches, and trigeminal neuralgia.","Consideration: $300K cash, $177,974 in installments through April 2024, 1M common shares, and assumption of $92K debt.","Formed Lucy Discoveries Holdings to advance psychedelic medicine R&D and diversify its therapy pipeline.","Wesana CEO Daniel Carcillo will join Lucy; transaction closed June 30, 2023, press release dated July 5."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-055368","json":"https://secwatch.observer/filing/0001213900-23-055368.json","markdown":"https://secwatch.observer/filing/0001213900-23-055368.md","text":"https://secwatch.observer/filing/0001213900-23-055368.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865127/000121390023055368/0001213900-23-055368-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865127/000121390023055368/ea181425-8k_lucyscien.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T11:16:57.049408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9a4a7019b78701512270f0f4c7792ec80f94d957","claim":"Lucy Scientific Discovery, Inc. completed an acquisition involving Wesana Health Holdings Inc. (closed 2023-06-30).","evidence_excerpt":"On June 30, 2023, the Closing occurred. A total of $100,000 was paid by the Company to Wesana on July 5, 2023 and the Shares were issued on June 30, 2023.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1865127/000121390023055368/0001213900-23-055368-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Wesana Health Holdings Inc."},{"label":"Closing","value":"2023-06-30"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}